Tokio Marine Asset Management Co. Ltd. lowered its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 72,681 shares of the healthcare conglomerate’s stock after selling 3,581 shares during the period. UnitedHealth Group accounts for approximately 2.4% of Tokio Marine Asset Management Co. Ltd.’s portfolio, making the stock its 3rd largest holding. Tokio Marine Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $16,023,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Exane Derivatives raised its position in shares of UnitedHealth Group by 15,333.3% in the fourth quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after buying an additional 460 shares in the last quarter. Bruderman Asset Management LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth $114,000. Acrospire Investment Management LLC raised its position in shares of UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after buying an additional 400 shares in the last quarter. Baystate Wealth Management LLC raised its position in shares of UnitedHealth Group by 64.9% in the fourth quarter. Baystate Wealth Management LLC now owns 762 shares of the healthcare conglomerate’s stock worth $186,000 after buying an additional 300 shares in the last quarter. Finally, Legacy Advisors LLC raised its position in shares of UnitedHealth Group by 546.0% in the fourth quarter. Legacy Advisors LLC now owns 801 shares of the healthcare conglomerate’s stock worth $176,000 after buying an additional 677 shares in the last quarter. Hedge funds and other institutional investors own 86.78% of the company’s stock.
In other news, CEO Steven H. Nelson sold 14,233 shares of the firm’s stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $230.22, for a total transaction of $3,276,721.26. Following the transaction, the chief executive officer now directly owns 18,219 shares of the company’s stock, valued at $4,194,378.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total value of $2,463,800.00. Following the transaction, the director now directly owns 76,637 shares in the company, valued at $18,881,824.06. The disclosure for this sale can be found here. Insiders have sold 67,015 shares of company stock worth $15,635,599 over the last ninety days. Insiders own 0.89% of the company’s stock.
UNH has been the topic of a number of recent analyst reports. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, December 27th. Evercore ISI reiterated an “outperform” rating and issued a $255.00 price objective (up previously from $235.00) on shares of UnitedHealth Group in a research report on Friday, January 12th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective on the stock in a research report on Saturday, January 20th. Wells Fargo reiterated an “outperform” rating and issued a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Finally, ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, December 7th. Two equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $245.14.
Shares of UnitedHealth Group Inc (NYSE:UNH) opened at $225.05 on Tuesday. UnitedHealth Group Inc has a 12-month low of $162.74 and a 12-month high of $250.79. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market capitalization of $220,491.67, a PE ratio of 21.01, a price-to-earnings-growth ratio of 1.33 and a beta of 0.74.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. During the same period last year, the firm earned $2.11 earnings per share. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. equities research analysts forecast that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be paid a dividend of $0.75 per share. The ex-dividend date is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.33%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 28.01%.
ILLEGAL ACTIVITY NOTICE: This news story was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.thelincolnianonline.com/2018/03/20/unitedhealth-group-inc-unh-holdings-lessened-by-tokio-marine-asset-management-co-ltd.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.